• Acalabrutinib (Acaluxen 100mg): Blood Cancer therapy Quick View
    • Acalabrutinib (Acaluxen 100mg): Blood Cancer therapy Quick View
    • ,

    • Acalabrutinib (Acaluxen 100mg): Blood Cancer therapy

    • Acalabrutinib, marketed under the brand name Acaluxen 100mg, is a breakthrough medication used in the treatment of specific Blood Cancer therapy, including mantle cell lymphoma (MCL) and chronic lymphocytic leukaemia (CLL). As a second-generation Bruton’s tyrosine kinase (BTK) inhibitor, Acalabrutinib works by blocking the activity of BTK, a protein that contributes to the growth and survival of cancer cells. This…
    • Read more